We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Mucosis Announces Positive Proof-Of-Concept Data for Mimopath® Platform in Humans

News   May 14, 2012

 
Mucosis Announces Positive Proof-Of-Concept Data for Mimopath® Platform in Humans
 
 
Advertisement
 

RELATED ARTICLES

Immune Disease Model Points to Treatment for COVID-19 Cytokine Storms

News

Researchers have developed a transgenic mouse to model the deadly childhood immune disease hemophagocytic lymphohistiocytosis, they hope that this model could aid development of a treatment for COVID-related cytokine storms

READ MORE

Attacking Cancer Cells With Viruses

News

Scientists have made an adenovirus that specifically replicates inside and kills cancer cells by employing special RNA-stabilizing elements.

READ MORE

Antibodies Can Be Made Rapidly in Chicken Cells

News

Scientists have developed a system that can generate human antibodies against various antigens faster than existing methods.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE